RECENT HIV TESTING AMONG GENERAL
HOSPITAL INPATIENTS WITH
SCHIZOPHRENIA: FINDINGS FROM FOUR
NEW YORK CITY SITES
James Walkup, Ph.D., Donna D. McAlpine, M.A., Mark Olfson,
M.D., M.P.H., Carol Boyer, Ph.D., and Steve Hansell, Ph.D.
Background: While widely acknowledged to be an important clinical and public
health issue, HIV assessment, counseling, and testing for the seriously mentally
ill has not been well studied. Objective: To determine what proportion and which
inpatients with schizophrenia have been recently tested for HIV. Method: A sam-
ple of 300 inpatients with schizophrenia were recruited from four general hospi-
tals in New York City over a one year period. After conﬁrmation of diagnosis
with a structured interview, and elicitation of sociodemographic and drug use
information, medical record review identiﬁed recent HIV testing. Bivariate and
multivariate analyses were used to identify subgroups more likely to be tested.
Findings: Recent HIV testing had been performed for 17% of the sample and
was concentrated among those with higher documented risks. The majority of
patients remain untested even in groups with direct risks, such as injection drug
use, and indirect risks, such as frequent cocaine use in last year. Some evidence
Dr. Walkup, Ms. McAlpine, Dr. Boyer, and Dr. Hansell are afﬁliated with the
Institute for Health, Health Care Policy, and Aging Research, Rutgers Univer-
sity. Dr. Olfson is afﬁliated with New York Psychiatric Institute.
Address correspondence to James Walkup, Ph.D., Institute for Health, Health
Care Policy, and Aging Research, Rutgers University, 30 College Ave-
nue, New Brunswick, New Jersey 08901; e-mail: email@example.com,
PSYCHIATRIC QUARTERLY, Vol. 71, No. 2, Summer 2000
0033-2720/00/0600-0177$18.00/0 2000 Human Sciences Press, Inc.